Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care

Area of Science:

• Endocrinology
• Cardiology
• Metabolic Disorders

Background:

• Cardiovascular disease (CVD) is the primary cause of death in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM).
• Individuals with diabetes mellitus (DM) face a 2-10 times higher risk of CVD compared to the general population.
• An atherogenic lipid profile, characterized by hypertriglyceridemia, is a key contributor to this elevated CVD risk.

Purpose of the Study:

• To review the pathophysiology of atherogenic hypertriglyceridemia in DM.
• To examine the evidence for triglycerides' independent role in CVD development.
• To discuss hypertriglyceridemia treatment in DM patients, focusing on pediatric relevance and data gaps.

Main Methods:

• Literature review of existing studies on DM, dyslipidemia, and CVD.
• Analysis of pathophysiological mechanisms linking hypertriglyceridemia to atherosclerosis in diabetes.
• Evaluation of current treatment strategies for hypertriglyceridemia in diabetic populations.

Main Results:

• Dyslipidemia, including hypertriglyceridemia, is observed in children and adolescents with DM, particularly T2DM and poorly controlled T1DM.
• The specific role of hypertriglyceridemia in the long-term CVD risk for diabetic youth remains insufficiently understood due to limited data.
• Evidence suggests triglycerides may play an independent role in CVD development, though more research is needed.

Conclusions:

• Hypertriglyceridemia is a significant concern in diabetes, potentially impacting cardiovascular health from a young age.
• There is a critical need for more research on hypertriglyceridemia and CVD in children and adolescents with DM.
• Further data are essential to guide clinical practice and develop targeted interventions for preventing CVD in diabetic youth.